DrugPatentWatch Database Preview
VELETRI Drug Profile
When do Veletri patents expire, and when can generic versions of Veletri launch?
Veletri is a drug marketed by Actelion Pharms Ltd and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in VELETRI is epoprostenol sodium. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.
Summary for VELETRI
| International Patents: | 18 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 19 |
| Clinical Trials: | 1 |
| Patent Applications: | 552 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VELETRI |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VELETRI |
| DailyMed Link: | VELETRI at DailyMed |
Pharmacology for VELETRI
| Drug Class | Prostacycline Vasodilator |
| Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for VELETRI
US Patents and Regulatory Information for VELETRI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-002 | Jun 28, 2012 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-001 | Jun 27, 2008 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-002 | Jun 28, 2012 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-001 | Jun 27, 2008 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for VELETRI
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 0. 5m/vial and1.5 mg/vial | ➤ Subscribe | ➤ Try a Free Trial |
International Patents for VELETRI
| Country | Document Number | Estimated Expiration |
|---|---|---|
| South Korea | 20090004867 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2007092343 | ➤ Try a Free Trial |
| Brazil | PI0707488 | ➤ Try a Free Trial |
| Denmark | 1993557 | ➤ Try a Free Trial |
| South Korea | 101351668 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
